MT-1 melatonin receptor expression increases the antiproliferative effect of melatonin on S-91 murine melanoma cells

Journal of Pineal Research

Volumn 36, Issue 3, 2004, Pages 204-211

  Kadekaro, Ana Luisa ^a,d   Andrade, Luciana N S ^a   Floeter Winter, Lucile M ^a   Rollag, Mark D ^b   Virador, Victoria ^c   Vieira, Wilfred ^c   Castrucci, Ana Maria De L ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Melatonin; Melatonin receptors; Murine melanoma; S 91 cell line; Tumor growth

Indexed keywords

ADENYLATE CYCLASE; ANTIOXIDANT; CALCIUM; CATALASE; CYCLIC AMP; GLUTATHIONE PEROXIDASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOASSAY; CALCIUM MOBILIZATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; MALE; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PINEAL BODY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; CATALASE; CELL DIVISION; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; GLUTATHIONE PEROXIDASE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; MALE; MELANOMA; MELATONIN; MICE; MICE, INBRED DBA; RECEPTOR, MELATONIN, MT1; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 1842557598     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00119.x     Document Type: Article

References (43)

1. REITER RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79:C153-C158.
2. RASMUSSEN DD. Diurnal modulation of rat hypothalamic gonadotropin- releasing hormone release by melatonin in vitro. J Endocrinol Invest 1993; 16:1-7.
3. VANECEK J. Melatonin inhibitory effect on luteinizing hormone release is potentiated after long pretreatment with the indole. Brain Res 1991; 538:329-332.
4. DREW JE, BARRET P, MERCER JG et al. Localization of the melatonin-related receptor in the rodent brain and peripheral tissues. J Neuroendocrinol 2001; 13:453-458.
5. HU DN, MCCORMICK SA, ROBERTS JE. Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells. Melanoma Res 1998; 8:205-210.
6. GEARY GG, DUCKLES SP, KRAUSE DN. Effect of melatonin in the rat tail artery: role of K + channels and endothelial factors. Br J Pharmacol 1998; 123:1533-1540.
7. DOOLEN S, KRAUSE DN, DUBOCOVICH ML, DUCKLES SP. Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 1998; 345:67-69.
8. REITER RJ, TAN D-X, OSUNA C, GITTO E. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Sci 2000; 7:444-458.
9. WITT-ENDERBY PA, BENNETT J, JARZYNKA MJ, FIRESTINE S, MELAN MA. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci 2003; 72:2183-2198.
10. COSTA EJ, LAMY-FREUND MT. Permeability of pure lipid bilayers to melatonin. J Pineal Res 1995; 19:123-126.
11. 3H-melatonin to calmodulin. Life Sci 1993; 53:201-207.
12. ACUNÃ-CASTROVIEJO D, PABLOS MI, MENENDEZ-PELAEZ A, REITER RJ. Melatonin receptors in purified cell nuclei of liver. Res Commun Chem Pathol Pharmacol 1993; 82:253-256.
13. TAN DX, CHEN LD, POEGGELER B, MANCHESTER LC, REITER RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine J 1993; 1:57-60.
14. REPPERT SM. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 1997; 12:528-531.
15. NOSJEAN O, FERRO M, COGE F et al. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 2000; 275:3111-3117.
16. BRYDON L, ROKA F, PETIT L et al. Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3) and G(q/11) proteins. Mol Endocrinol 1999; 13:2025-2038.
17. HO MK, YUNG LY, CHAN JS, CHAN JH, WONG CS, WONG YH. G alpha(14) links a variety of G(i)-and G(s)-coupled receptors to the stimulation of phospholipase C. Br J Pharmacol 2001; 132:1431-1440.
18. CHAN AS, LAI FP, LO RK, VOYNO-YASENETSKAYA TA, STANBRIDGE EJ, WONG YH. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signal 2002; 14:249-257.
19. DUBOCOVICH ML. Pharmacology and function of melatonin receptors. FASEB J 1988; 2:2765-2773.
20. DUBOCOVICH ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995; 16:50-56.
21. EBISAWA TS, KARNE S, LERNER MR, REPPERT SM. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Nat Acad Sci USA 1994; 91:6133-6137
22. REPPERT SM, WEAVER DR, EBISAWA T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13:1177-1185.
23. REPPERT SM, WEAVER DR, GODSON C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci 1996; 17:100-102.
24. GODSON C, REPPERT SM. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 1997; 138:397-404.
25. WEAVER DR, STEHLE JH, STOPA EG, REPPERT SM. Melatonin receptors in human hypothalamus and pituitary: implications for circadian and reproductive responses to melatonin. J Clin Endocrinol Metab 1993; 76:295-301.
26. LIU C, WEAVER DR, JIN X et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997; 19:91-102.
27. VON GALL C, STEHLE JH, WEAVER DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res 2002; 309:151-162.
28. SPECTOR T. Refinement of the Coomassie blue method of protein quantification. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein. Anal Biochem 1978; 86:142-146.
29. HOSOI J, ABE E, SUDA T, KUROKI T. Regulation of melanin synthesis of B16 mpuse melanoma cells by alpha,25-dihydroxyvitamin D3 and retinoic acid. Cancer Res 1985; 45:1474-1478.
30. BEUTLER E. Catalase. In: Red Cell Metabolism. Beutler E, ed., 1974; pp. 88-89, Grune & Stratton, NY, USA.
31. ROCA AL, GODSON C, WEAVER DR, REPPERT SM. Structure, characterization and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology 1996; 137:3469-3477.
32. BOUSSIF O, LEZOUALC'H F, ZANTA MA et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Nat Acad Sci USA 1995; 92:7297-7301.
33. DAS GUPTA TK, TERZ J. Influence of pineal gland on the growth and spread of melanoma in hamster. Cancer Res 1967; 48:6121-6126.
34. STANBERRY LR, DAS GUPTA TK, BEATTIE CW. Photoperiodic control of melanoma growth in hamsters: influence of pinealectomy and melatonin. Endocrinology 1983; 113:469-475.
35. NARITA T, KUDO H. Effect of melatonin on B16 melanoma growth in athymic mice. Cancer Res 1985; 45:4175-4177.
36. SLOMINSKI A, PISARCHIK A, SEMAK I et al. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 2002; 16:896-898.
37. WEATHERHEAD B, BLACKBURN MEC. Growth and melanization of a hamster melanoma cell line, RPMI 3460, in response to melatonin and cyclic nucleotides. In: Pigment Cell Biological, Molecular and Clinical Aspects of Pigmentation. Bagnara J, Klaus SN, Paul E, Schartl M, eds., 1985; pp. 453-461.
38. SLOMINSKI A, PRUSKI D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 1993; 206:189-194.
39. BENITEZ-KING G, HUERTO-DELGADILLO L, ANTON-TAY F. Melatonin modifies calmodulin cell levels in MDCK and neuroblastoma N1E-115 cell lines and inhibits phosphodiesterase activity in vitro. Brain Res 1991; 557:289-292.
40. COS SJ, SANCHEZ-BARCELO EJ. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sci 1996; 58:811-816.
41. MAHARAJ DS, ANOOPKUMAR-DUKIE S, GLASS BD et al. The identification of the UV degradants of melatonin and their ability to scavange free radicals. J Pineal Res 2002; 32: 245-261.
42. HAZLERIGG DC, GONZALEZ-BRITO A, LAWSON W, HASTINGS MH, MORGAN PJ. Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology 1993; 132:285-292.
43. FILADELFI AMC, CASTRUCCI AML. Melatonin desensitizing effects on the in vitro responses to MCH, alpha-MSH, isoproterenol and melatonin in pigment cells of a fish (S. marmoratus), a toad (B. ictericus), a frog (R. pipiens), and a lizard (A. carolinensis), exposed to varying photoperiodic regimens. Comp Biochem Physiol 1994; 109A:1027-1037.